Abstract
Angina is a pain in the chest or adjacent areas caused by severe, but temporary, lack of blood (ischemia) to a segment of the heart muscle, hence the term myocardial ischemia. For stable angina, the most important feature is the causation of pain by a particular exertional activity and relief within minutes of cessation of the precipitating activity.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abrams J. Interval therapy to avoid nitrate tolerance: paradise regained. Am J Cardiol. 1989;64:931.
Cairns JA, Gent M, Singer J, et al. Aspirin, sulfinpyrazone or both in unstable angina. N Engl J Med. 1985;313:1369.
Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495–504 [Erratum, N Engl J Med 2006;354:778.].
CAPRICORN investigators. Effect of carvedilol on outcome after myocardial infarction in patients with LV dysfunction. Lancet. 2001;357:1385.
Cohn PF. Total ischemic burden: pathophysiology and prognosis. Am J Cardiol. 1987;59:3C.
COURAGE Boden WE, O’Rourke RA, Teo KK, et al. for the COURAGE trial research. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503–1516.
Cruickshank JM. Beta-blockers continue to surprise us. Eur Heart J. 2000;21:354.
Elkayam U. Tolerance to organic nitrates: evidence, mechanisms, clinical relevance and strategies for prevention. Ann Intern Med. 1991;114:667.
Fihn SD, Blankenship JC, Alexander KP, et al. ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2014;28:2014. doi:10.1016/j.jacc.2014.07.017.
George S, Cockburn J, Clayton TC. Long-term follow-up of elective chronic total coronary occlusion angioplasty analysis from the U.K. Central Cardiac Audit Database. J Am Coll Cardiol. 2014;64:235–43.
Gottlieb SO, Weisfeldt ML, Ouyang P, et al. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina. N Engl J Med. 1986;314:1214.
Grosser T, Fries S, Lawson JA, et al. Drug resistance and pseudoresistance an unintended consequence of enteric coating Aspirin. Circulation. 2013;127:377–85.
Hobl E, Stimlfl T, Ebner J, et al. Morphine decreases clopidogrel concentrations and effects. A randomized double—blind placebo-controlled trial. J Am Coll Cardiol. 2014;63(7):630–5.
Juul Moller S, Edvardsson N, Jhnmatz B, et al. Double blind trial of aspirin in primary prevention of myocardial infarction in patients with stable angina pectoris. Lancet. 1992;340:1421.
Juurlink DN, Gomes T, Ko DT, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ. 2009;180:713–8.
Khan MG. Angina. In: Heart disease, diagnosis and therapy. Totowa, NJ: Humana Press, 2005, p. 55.
Lewis HD, Davis JW, Archibald DG, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: results of a Veterans Administration Cooperative Study. N Engl J Med. 1983;309:396.
Mega JL, Braunwald E, Wiviott SD, et al. Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med. 2012;366:9–19.
Miwa K, Kambara H, Kawai C. Effect of aspirin in large doses on attacks of variant angina. Am Heart J. 1983;105:351.
Nademanee K, Intarachot V, Josephson MA, et al. Prognostic significance of silent myocardial ischemia in patients with unstable angina. J Am Coll Cardiol. 1987;10:1.
Norwegian MultiCenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med. 1981;304:801.
O’Rourke RA. Optimal medical therapy is a proven option for chronic stable angina. J Am Coll Cardiol. 2008a;52:905–7.
Packer M, Le WH, Kessler P, et al. Induction of nitrate tolerance in heart failure by continuous infusion of nitroglycerin and reversal of tolerance by N-acetylcysteine, a sulfhydryl donor (abstract). J Am Coll Cardiol. 1986;7:27A.
Peterson ED, Rumsfeld JS. Finding the courage to reconsider medical therapy for stable angina. N Engl J Med. 2008;359:751–3.
PRAISE, Packer M, O’Connor CM, Ghoul JK, et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation study group. N Engl J Med. 1996;335:1107.
Rudolph W. Tolerance development during isosorbide dinitrate treatment: can it be circumvented? Z Kardiol. 1983;72:195.
Schömig A, Mehilli J, de Waha A, et al. A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease. J Am Coll Cardiol. 2008;52:894–904.
Sharpe N, Coxon R, Webster M, et al. Hemodynamic effects of intermittent transdermal nitroglycerin in chronic congestive heart failure. Am J Cardiol. 1987;59:895.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Khan, M.G. (2015). Angina. In: Cardiac Drug Therapy. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-962-4_10
Download citation
DOI: https://doi.org/10.1007/978-1-61779-962-4_10
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-961-7
Online ISBN: 978-1-61779-962-4
eBook Packages: MedicineMedicine (R0)